Monographie - Urokinase

Ultimo aggiornamento :
19/11/2024

Urokinase

Nome commerciale

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Abbokinase	Austria, Chile, Spagna, Stati Uniti d’America, Svezia
Actosolv	Belgio, Francia, Italia, Lussemburgo
Alfakinasi	Italia
Angikinase	Egitto
Corase	Germania
Dabunase	India
Dukinase	India
KD Unase	India
Kisolv	Italia
Lynlitic	Canada
Medacinase	Paesi Bassi
Persolv	Italia
Rheotromb	Germania
Syner-Kinase	Gran Bretagna
Ukidan	Grecia
Urochinasi	Italia
Urokinasa	Polonia
Urokinase	Austria, Germania, Lussemburgo, Malaysia, nuova Zelanda, Paesi Bassi, Spagna, Svizzera
Uroquidan	Spagna
Uroquinasa	Chile

Bibliografia : Urokinase

	tipo	pubblicazione
375	Rivista	Patel JP, Tran LT, Sinai WJ, Carr LJ. Activity of urokinase diluted in 0.9% sodium chloride injection or 5% dextrose injection and stored in glass or plastic syringes. Am J Hosp Pharm 1991 ; 48: 1511-1514.
1061	Rivista	Rhoney DH, Coplin WM, Zaran FK, Brish LK, Weingarten CM. Urokinase after freezing : Implications for thrombolysis in intraventricular hemorrhage. Am J Health-Syst Pharm 1999 ; 56: 2047-2051.
1394	Rivista	Zimmermann R, Sch?ffel G, Harenberg J. Urokinase therapy: dose reduction by administration in plastic material. Thromb Haemost 1981 ; 45: 296.
1395	Rivista	Toki N, Sumi H. Glass adsorption of highly purified urokinase. Thromb Haemost 1980 ; 43: 67.
1941	Rivista	Dedrick SC, Ramirez-Rico J. Potency and stability of frozen urokinase solutions in syringes. Am J Health-Syst Pharm 2004 ; 61: 1586-1589.
2050	Rivista	Kohles JD, Weld M, Asa?d H, Gunning P, Reid Sterrett J, Debari VA. Stability of reconstituted urokinase solutions. Current Ther Res 2000 ; 61: 1-6

Mentions Légales